WELAB BARCELONA

At Welab Barcelona, we believe that Partnership in biomedical innovation has the potential to bring innovative treatments to patients.

People is the real driving force of any endeavor. Ideas come from people, and research and development of new drugs is performed by people. True innovation will come from the vision, expertise, and talent of people. Innovation has many ingredients, but a single formula: COLLABORATION. Welab Barcelona is actively looking for partnership and collaborations with pharmaceutical industry, acaedmia, research centers, CROs, and patient organizations. It is our strong conviction that this is the best way for dealing with the great challenges faced by medical research, and for providing new treatments for unmet therapeutic needs.

WELAB BARCELONA

PARTNERS

WELAB BARCELONA

COLLABORATIVE PROJECTS

WELAB BARCELONA

CLIENTS

Dear colleagues, collaborators, and friends,

After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team.

We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients.

As we bid farewell, let’s cherish the memories we’ve created, the bonds we’ve formed, and the impact we’ve made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure.

We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges.

With heartfelt appreciation,

Welab’s team

We are proud to announce that Welab is partner of this new EU funded project.

In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS